002940 昂利康
已收盘 06-05 15:00:00
资讯
新帖
简况
6月5日昂利康跌9.83%，国泰海通新锐量化选股混合A基金重仓该股
证券之星 · 06-05 16:42
6月5日昂利康跌9.83%，国泰海通新锐量化选股混合A基金重仓该股
昂利康（002940）披露获得化学原料药上市申请批准通知书，6月2日股价下跌3.46%
证券之星 · 06-02
昂利康（002940）披露获得化学原料药上市申请批准通知书，6月2日股价下跌3.46%
昂利康(002940.SZ)：阿莫西林与氨苄西林获批上市
智通财经 · 06-02
昂利康(002940.SZ)：阿莫西林与氨苄西林获批上市
昂利康(002940.SZ)：子公司异氟烷获得药品注册证书
智通财经 · 06-01
昂利康(002940.SZ)：子公司异氟烷获得药品注册证书
昂利康（002940）披露2025年度股东会决议公告，5月29日股价下跌1.41%
证券之星 · 05-29
昂利康（002940）披露2025年度股东会决议公告，5月29日股价下跌1.41%
昂利康(002940.SZ)：氟伐他汀钠缓释片获得药品注册证书
智通财经 · 05-29
昂利康(002940.SZ)：氟伐他汀钠缓释片获得药品注册证书
股市必读：新发布《浙江昂利康制药股份有限公司与东方证券股份有限公司关于浙江昂利康制药股份有限公司申请向特定对象发行股票的审核问询函的回复》
证券之星 · 05-28
股市必读：新发布《浙江昂利康制药股份有限公司与东方证券股份有限公司关于浙江昂利康制药股份有限公司申请向特定对象发行股票的审核问询函的回复》
昂利康（002940）披露2025年度向特定对象发行A股股票预案（二次修订稿），5月27日股价上涨2.56%
证券之星 · 05-27
昂利康（002940）披露2025年度向特定对象发行A股股票预案（二次修订稿），5月27日股价上涨2.56%
昂利康（002940）披露股票交易异常波动公告，5月25日股价下跌10.0%
证券之星 · 05-25
昂利康（002940）披露股票交易异常波动公告，5月25日股价下跌10.0%
昂利康最新公告：公司不涉及光芯片等半导体领域的业务和投资行为
证券之星 · 05-25
昂利康最新公告：公司不涉及光芯片等半导体领域的业务和投资行为
5月25日昂利康（002940）龙虎榜数据：机构净卖出1926.75万元
证券之星 · 05-25
5月25日昂利康（002940）龙虎榜数据：机构净卖出1926.75万元
5月25日昂利康跌10.00%，国泰海通新锐量化选股混合A基金重仓该股
证券之星 · 05-25
5月25日昂利康跌10.00%，国泰海通新锐量化选股混合A基金重仓该股
异动快报：昂利康（002940）5月25日11点9分触及跌停板
证券之星 · 05-25
异动快报：昂利康（002940）5月25日11点9分触及跌停板
5月22日昂利康（002940）龙虎榜数据：机构净买入427.34万元，北向资金净卖出2391.13万元
证券之星 · 05-22
5月22日昂利康（002940）龙虎榜数据：机构净买入427.34万元，北向资金净卖出2391.13万元
异动快报：昂利康（002940）5月22日10点19分触及跌停板
证券之星 · 05-22
异动快报：昂利康（002940）5月22日10点19分触及跌停板
昂利康（002940）披露副总经理辞职公告，5月21日股价上涨10.0%
证券之星 · 05-21
昂利康（002940）披露副总经理辞职公告，5月21日股价上涨10.0%
5月21日昂利康（002940）涨停分析：业绩高增、创新药进展与宠物药放量驱动
证券之星 · 05-21
5月21日昂利康（002940）涨停分析：业绩高增、创新药进展与宠物药放量驱动
异动快报：昂利康（002940）5月20日10点24分触及跌停板
证券之星 · 05-20
异动快报：昂利康（002940）5月20日10点24分触及跌停板
昂利康（002940）披露获得瑞舒伐他汀依折麦布片（I）《药品注册证书》，5月18日股价下跌2.96%
证券之星 · 05-18
昂利康（002940）披露获得瑞舒伐他汀依折麦布片（I）《药品注册证书》，5月18日股价下跌2.96%
股市必读：昂利康（002940）登5月15日交易所龙虎榜
证券之星 · 05-18
股市必读：昂利康（002940）登5月15日交易所龙虎榜
加载更多
公司概况
公司名称：
浙江昂利康制药股份有限公司
所属行业：
医药制造业
上市日期：
2018-10-23
主营业务：
浙江昂利康制药股份有限公司的主营业务是化学原料药、化学制剂及特色中间体系列产品的研发、生产和销售。公司的主要产品是抗感染类、心血管类、泌尿系统类（肾病类）、麻醉疼痛类、抗雄性激素类。
发行价格：
23.07
{"stockData":{"symbol":"002940","market":"SZ","secType":"STK","nameCN":"昂利康","latestPrice":31.75,"timestamp":1780642998000,"preClose":35.21,"halted":0,"volume":28668881,"delay":0,"changeRate":-0.0983,"floatShares":185000000,"shares":202000000,"eps":0.6306,"marketStatus":"已收盘","change":-3.46,"latestTime":"06-05 15:00:00","open":35.72,"high":36.2,"low":31.69,"amount":939000000,"amplitude":0.1281,"askPrice":31.76,"askSize":19,"bidPrice":31.75,"bidSize":510,"shortable":0,"etf":0,"ttmEps":0.6306,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780882200000},"marketStatusCode":5,"adr":0,"adjPreClose":35.21,"symbolType":"stock","openAndCloseTimeList":[[1780623000000,1780630200000],[1780635600000,1780642800000]],"highLimit":38.73,"lowLimit":31.69,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":201728186,"isCdr":false,"pbRate":4.32,"roa":"--","peRate":50.348874,"roe":"1.08%","epsLYR":0.62,"committee":0.831933,"marketValue":6405000000,"turnoverRate":0.1547,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-06-08。","floatMarketCap":5882000000},"requestUrl":"/m/hq/s/002940","defaultTab":"news","newsList":[{"id":"2641116504","title":"6月5日昂利康跌9.83%，国泰海通新锐量化选股混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641116504","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641116504?lang=zh_cn&edition=full","pubTime":"2026-06-05 16:42","pubTimestamp":1780648963,"startTime":"0","endTime":"0","summary":"证券之星消息，6月5日昂利康跌9.83%，收盘报31.75元，换手率15.47%，成交量28.67万手，成交额9.39亿元。国泰海通新锐量化选股混合A目前规模为0.2亿元，最新净值1.4249，较上一交易日下跌0.13%。国泰海通新锐量化选股混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500028397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0184","BK1147","BK0239","02611","BK0276","BK0012","BK0183","BK0201","BK1564","BK0028","601211","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640994954","title":"昂利康（002940）披露获得化学原料药上市申请批准通知书，6月2日股价下跌3.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640994954","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640994954?lang=zh_cn&edition=full","pubTime":"2026-06-02 22:13","pubTimestamp":1780409632,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，昂利康报收于33.18元，较前一交易日下跌3.46%，最新总市值为66.93亿元。该股当日开盘34.96元，最高34.98元，最低32.61元，成交额达4.27亿元，换手率为6.91%。近日，浙江昂利康制药股份有限公司收到国家药品监督管理局签发的《化学原料药上市申请批准通知书》，阿莫西林和氨苄西林原料药获批注册。目前国内已有包括公司在内的多家企业取得阿莫西林和氨苄西林原料药A状态登记，市场竞争较为激烈。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200047156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640919357","title":"昂利康(002940.SZ)：阿莫西林与氨苄西林获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2640919357","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640919357?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:12","pubTimestamp":1780391566,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昂利康 发布公告，近日，公司收到国家药品监督管理局签发的《化学原料药上市申请批准通知书》。公司分别于2024年12月、2025年1月递交了阿莫西林原料药、氨苄西林原料药的药品注册申请，于2025年1月获得受理，并于近日获得国家药监局批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449097.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640937633","title":"昂利康(002940.SZ)：子公司异氟烷获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2640937633","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640937633?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:04","pubTimestamp":1780304645,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昂利康(002940.SZ)发布公告，近日，公司子公司福建海西联合药业有限公司收到国家药品监督管理局签发的异氟烷《药品注册证书》。据悉，异氟烷可用于全身麻醉的诱导和维持。此次获得《药品注册证书》视同通过一致性评价，将进一步丰富公司的仿制药产品管线，增强公司的综合竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639673117","title":"昂利康（002940）披露2025年度股东会决议公告，5月29日股价下跌1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639673117","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639673117?lang=zh_cn&edition=full","pubTime":"2026-05-29 22:15","pubTimestamp":1780064124,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，昂利康报收于35.0元，较前一交易日下跌1.41%，最新总市值为70.6亿元。该股当日开盘35.8元，最高36.28元，最低34.52元，成交额达6.07亿元，换手率为9.29%。近日，浙江昂利康制药股份有限公司发布《2025年度股东会决议公告》。公告显示，公司于2026年5月29日召开2025年度股东会，会议审议通过了《2025年度董事会工作报告》《2025年度财务决算报告》《2025年度利润分配预案》《2025年年度报告及摘要》等议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900046210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639629948","title":"昂利康(002940.SZ)：氟伐他汀钠缓释片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2639629948","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639629948?lang=zh_cn&edition=full","pubTime":"2026-05-29 18:18","pubTimestamp":1780049922,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昂利康(002940.SZ)发布公告，近日，公司收到国家药品监督管理局签发的氟伐他汀钠缓释片《药品注册证书》。据悉，氟伐他汀钠缓释片用于饮食未能完全控制的原发性高胆固醇血症和混合型血脂异常(Fredrickson II a及II b型)的患者。根据国家相关政策规定，此次获得《药品注册证书》视同通过一致性评价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昂利康(002940.SZ)：氟伐他汀钠缓释片获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638687280","title":"股市必读：新发布《浙江昂利康制药股份有限公司与东方证券股份有限公司关于浙江昂利康制药股份有限公司申请向特定对象发行股票的审核问询函的回复》","url":"https://stock-news.laohu8.com/highlight/detail?id=2638687280","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638687280?lang=zh_cn&edition=full","pubTime":"2026-05-28 01:17","pubTimestamp":1779902228,"startTime":"0","endTime":"0","summary":"公司公告汇总浙江昂利康制药股份有限公司于2026年5月26日召开第四届董事会第十九次会议，审议通过关于调整公司2025年度向特定对象发行A股股票方案的议案。本次投资无需提交董事会或股东会审议，不构成关联交易或重大资产重组。业绩披露要点浙江昂利康制药股份有限公司2025年度财务报告经审计，审计意见为标准无保留意见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800000959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1564","BK0183","BK0012","BK0239","03958","BK0028","BK0276","BK1147","BK0188","01477","600958","002940","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638864816","title":"昂利康（002940）披露2025年度向特定对象发行A股股票预案（二次修订稿），5月27日股价上涨2.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638864816","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638864816?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:13","pubTimestamp":1779891194,"startTime":"0","endTime":"0","summary":"截至2026年5月27日收盘，昂利康报收于36.88元，较前一交易日上涨2.56%，最新总市值为74.4亿元。该股当日开盘35.95元，最高38.99元，最低35.24元，成交额达7.87亿元，换手率为11.34%。近日，浙江昂利康制药股份有限公司披露《2025年度向特定对象发行A股股票预案》。公告显示，公司拟向特定对象发行A股股票，募集资金总额111,000.00万元，用于创新药研发项目。本次发行尚需深交所审核通过及中国证监会同意注册。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700045899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","399300","002940","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638555378","title":"昂利康（002940）披露股票交易异常波动公告，5月25日股价下跌10.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638555378","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638555378?lang=zh_cn&edition=full","pubTime":"2026-05-25 22:08","pubTimestamp":1779718099,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，昂利康报收于36.98元，较前一交易日下跌10.0%，最新总市值为74.6亿元。该股当日开盘39.2元，最高39.95元，最低36.98元，成交额达7.67亿元，换手率为10.93%。近日，浙江昂利康制药股份有限公司发布《股票交易异常波动公告》。公告显示，公司股票连续2个交易日收盘价格跌幅偏离值累计超过20%，构成异常波动。公司及控股股东不存在应披露未披露的重大事项，股票交易异常波动期间无买卖行为。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500033922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638553790","title":"昂利康最新公告：公司不涉及光芯片等半导体领域的业务和投资行为","url":"https://stock-news.laohu8.com/highlight/detail?id=2638553790","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638553790?lang=zh_cn&edition=full","pubTime":"2026-05-25 19:21","pubTimestamp":1779708065,"startTime":"0","endTime":"0","summary":"昂利康(002940)公告称，公司股票连续2个交易日(5月22日、25日)收盘价格跌幅偏离值累计超过20%。公司近期关注到有关自媒体、财经股吧等网络平台有个别用户发表涉及“聊聊昂利康，深度挖掘他的逻辑，很可能是光芯片的新玩家”“昂利康实控人体外孵化，新公司对标新易盛源杰”等内容。经公司自查，截止目前，公司不涉及光芯片等半导体领域的业务和投资行为，公司实际控制人吕慧浩及其近亲属仅持有浙江嵊熠光电有限公司（以下简称“嵊熠光电”）部分少数股权，系其及其近亲属的个人对外财务性投资，嵊熠光电与公司不存在业务合作关系。以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500027906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159813","002940","BK0239","159582"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638953161","title":"5月25日昂利康（002940）龙虎榜数据：机构净卖出1926.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638953161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638953161?lang=zh_cn&edition=full","pubTime":"2026-05-25 17:37","pubTimestamp":1779701866,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年5月25日公布的交易公开信息显示，昂利康因日跌幅偏离值达到7%的前5只证券，连续三个交易日内，跌幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年5月25日收盘，昂利康报收于36.98元，下跌10.0%，已连续跌停2天，换手率10.93%，成交量20.25万手，成交额7.67亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出1926.75万元。以上内容为证券之星据公开信息整理，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500024839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638443536","title":"5月25日昂利康跌10.00%，国泰海通新锐量化选股混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638443536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638443536?lang=zh_cn&edition=full","pubTime":"2026-05-25 16:41","pubTimestamp":1779698480,"startTime":"0","endTime":"0","summary":"证券之星消息，5月25日昂利康跌10.00%，收盘报36.98元，换手率10.93%，成交量20.25万手，成交额7.67亿元。重仓昂利康的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为国泰海通资管的国泰海通新锐量化选股混合A。国泰海通新锐量化选股混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500022914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0276","BK0188","BK1564","601211","BK1147","BK0201","02611","002940","BK0239","BK0028","BK0184","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638584885","title":"异动快报：昂利康（002940）5月25日11点9分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2638584885","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638584885?lang=zh_cn&edition=full","pubTime":"2026-05-25 11:10","pubTimestamp":1779678645,"startTime":"0","endTime":"0","summary":"证券之星5月25日盘中消息，11点9分昂利康（002940）触及跌停板。其所属行业化学制药目前下跌。领涨股为双成药业。该股为合成生物，医药，化学原料药概念热股。5月22日的资金流向数据方面，主力资金净流出7406.92万元，占总成交额10.61%，游资资金净流入7466.39万元，占总成交额10.7%，散户资金净流出59.47万元，占总成交额0.09%。近5日资金流向一览见下表：昂利康主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500010417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637909703","title":"5月22日昂利康（002940）龙虎榜数据：机构净买入427.34万元，北向资金净卖出2391.13万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637909703","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637909703?lang=zh_cn&edition=full","pubTime":"2026-05-22 17:33","pubTimestamp":1779442402,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年5月22日公布的交易公开信息显示，昂利康因日跌幅偏离值达到7%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年5月22日收盘，昂利康报收于41.09元，下跌9.99%，跌停，换手率9.1%，成交量16.85万手，成交额6.98亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入427.34万元，北向资金合计净卖出2391.13万元。以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200032577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637361072","title":"异动快报：昂利康（002940）5月22日10点19分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2637361072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637361072?lang=zh_cn&edition=full","pubTime":"2026-05-22 10:20","pubTimestamp":1779416433,"startTime":"0","endTime":"0","summary":"证券之星5月22日盘中消息，10点19分昂利康（002940）触及跌停板。其所属行业化学制药目前下跌。领涨股为科伦药业。该股为合成生物，化学原料药，医药概念热股，当日合成生物概念上涨0.08%。5月21日的资金流向数据方面，主力资金净流入7988.95万元，占总成交额8.75%，游资资金净流出3656.24万元，占总成交额4.01%，散户资金净流出4332.71万元，占总成交额4.75%。近5日资金流向一览见下表：昂利康主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200014504.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637342163","title":"昂利康（002940）披露副总经理辞职公告，5月21日股价上涨10.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637342163","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637342163?lang=zh_cn&edition=full","pubTime":"2026-05-21 22:11","pubTimestamp":1779372675,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，昂利康报收于45.65元，较前一交易日上涨10.0%，最新总市值为92.09亿元。公告显示，公司董事会于近日收到副总经理杨国栋先生递交的书面辞职报告，其因个人原因申请辞去公司副总经理职务，辞职报告自送达董事会之日起生效。辞去副总经理职务后，杨国栋先生仍担任子公司其他职务。截至公告日，杨国栋先生直接持有公司1.44%股权，持有控股股东嵊州市君泰投资有限公司1.47%股权，并通过员工持股计划间接持有公司0.08%股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100044255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637388893","title":"5月21日昂利康（002940）涨停分析：业绩高增、创新药进展与宠物药放量驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2637388893","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637388893?lang=zh_cn&edition=full","pubTime":"2026-05-21 15:33","pubTimestamp":1779348831,"startTime":"0","endTime":"0","summary":"证券之星消息，昂利康5月21日涨停收盘，收盘价45.65元。5月21日昂利康涨停的可能因素有：2025年归母净利润同比大增56.15%、扣非净利增78.82%，核心制剂业务营收增长超20%；定增11.2亿元获深交所受理，全部投向创新药ALK-N001Ⅰ期临床；富马酸伏诺拉生片获批双规格注册证书；宠物麻醉药批文落地且销量倍增；头孢全酶法工艺及阿莫西林技改强化原料药一体化能力。近5日资金流向一览见下表：该股为创新药，医药，化学原料药概念热股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100023617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159992","BK1574","06978","BK1161","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636891292","title":"异动快报：昂利康（002940）5月20日10点24分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2636891292","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636891292?lang=zh_cn&edition=full","pubTime":"2026-05-20 10:25","pubTimestamp":1779243929,"startTime":"0","endTime":"0","summary":"证券之星5月20日盘中消息，10点24分昂利康（002940）触及跌停板。其所属行业化学制药目前下跌。领涨股为奥赛康。该股为创新药，医药，化学原料药概念热股。5月19日的资金流向数据方面，主力资金净流入7172.85万元，占总成交额8.05%，游资资金净流出6033.82万元，占总成交额6.77%，散户资金净流出1139.03万元，占总成交额1.28%。近5日资金流向一览见下表：昂利康主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000014368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636029469","title":"昂利康（002940）披露获得瑞舒伐他汀依折麦布片（I）《药品注册证书》，5月18日股价下跌2.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636029469","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636029469?lang=zh_cn&edition=full","pubTime":"2026-05-18 17:31","pubTimestamp":1779096702,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘，昂利康报收于41.95元，较前一交易日下跌2.96%，最新总市值为84.62亿元。近日，浙江昂利康制药股份有限公司收到国家药品监督管理局签发的瑞舒伐他汀依折麦布片《药品注册证书》。药品通用名称为瑞舒伐他汀依折麦布片，主要成分为瑞舒伐他汀钙和依折麦布，剂型为片剂，注册分类为化学药品4类，视同通过一致性评价。截至2026年5月14日，共有11家企业视同通过一致性评价，市场竞争较为激烈，后续销售存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800026515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636156630","title":"股市必读：昂利康（002940）登5月15日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2636156630","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636156630?lang=zh_cn&edition=full","pubTime":"2026-05-18 02:44","pubTimestamp":1779043454,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，昂利康报收于43.23元，上涨7.89%，换手率28.78%，成交量53.32万手，成交额22.41亿元。龙虎榜上榜沪深交易所2026年5月15日公布的交易公开信息显示，昂利康因日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。公司公告汇总股票交易异常波动公告浙江昂利康制药股份有限公司股票连续2个交易日收盘价格涨幅偏离值累计超过20%，构成股票交易异常波动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800001149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780847023750,"stockEarnings":[{"period":"1week","weight":-0.0929},{"period":"1month","weight":-0.0422},{"period":"3month","weight":0.0332},{"period":"6month","weight":-0.158},{"period":"1year","weight":0.7893},{"period":"ytd","weight":-0.0528}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0318},{"period":"3month","weight":-0.0234},{"period":"6month","weight":0.032},{"period":"1year","weight":0.1902},{"period":"ytd","weight":0.0148}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江昂利康制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"40232人(较上一季度增加1.85%)","perCapita":"4605股","listingDate":"2018-10-23","address":"浙江省绍兴市嵊州市嵊州大道北1000号","registeredCapital":"20172万元","survey":" 浙江昂利康制药股份有限公司的主营业务是化学原料药、化学制剂及特色中间体系列产品的研发、生产和销售。公司的主要产品是抗感染类、心血管类、泌尿系统类（肾病类）、麻醉疼痛类、抗雄性激素类。","listedPrice":23.07},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昂利康(002940)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昂利康(002940)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昂利康,002940,昂利康股票,昂利康股票老虎,昂利康股票老虎国际,昂利康行情,昂利康股票行情,昂利康股价,昂利康股市,昂利康股票价格,昂利康股票交易,昂利康股票购买,昂利康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昂利康(002940)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昂利康(002940)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}